Sector portfolio · Private equity · United States
Goldman Sachs' Biotech portfolio
Goldman Sachs has backed 21 Biotech startups in rounds we track, $4.2B between them, shown by the stage each has reached. The best-funded is Zymergen.
21startups backed
4stages
$4.2Braised between them
Series C and laterbiggest stage
Funding by segment
- Series C and later$2.2B8
- Stage not reported$918M5
- Series B$938M5
- Series A$189M3
Where they are based
- United States17$3.9B
- Poland1$141M
- China1$108M
- United Kingdom1$100M
United States
Poland
China
United KingdomFounded
6Earlier
12
113
14
15
216
117
18
219
120
121
22
123
124
25
26
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M0
- $50M to $250M15
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
16 of 21 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States17
- Poland1
- China1
- United Kingdom1
Startups by country, 4 countries in all.
Segment by segment
Series C and later
8 startups · $2.2B raised
ZymergenUnited States$874M
Beacon TherapeuticsBeacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States$247M
Arcutis BiotherapeuticsArcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.United States$245M
CounsylCounsyl is a health technology company that offers DNA screening for men, women, and their children.United States$207M
Triveni BioTriveni Bio is a clinical-stage biotechnology company based in Watertown, Massachusetts, founded in 2019 through the merger of AmaUnited States$180M
TraceLinkTraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain.United States$174M
Doctor on DemandDoctor On Demand is a nationwide virtual healthcare provider based in San Francisco, offering 24/7 access to board-certified physiUnited States$161M
Ajax TherapeuticsAjax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.United States$95M
Stage not reported
5 startups · $918M raised
Outcome HealthOutcome Health is a prominent healthcare technology company based in Chicago, Illinois, focused on enhancing patient care through United States$600M- DDocPlannerPoland$141M
Entrada TherapeuticsEntrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.United States$100M
DrFirstDrFirst provides software solutions for physicians and healthcare providers ranging from HIPAA secure messaging, e-prescribing, and EHR.United States$68M
Silver Creek PharmaceuticalsSilver Creek Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines for patients in need.United States$9.2M
Series B
5 startups · $938M raised
- VBViela BioViela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.United States$325M
AscletisAscletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.United States$255M
MOMA TherapeuticsMOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$150M- RRimagRimag is a Shenzhen-based medical imaging service provider.China$108M
VicebioVicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.United Kingdom$100M
Series A
3 startups · $189M raised
Newleos TherapeuticsNewleos Therapeutics is a clinical-stage neuroscience and biotechnology company based in Boston, Massachusetts.United States$94M
Nested TherapeuticsNested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$90M- OOrthomimeticsOrthomimetics develops bio-material products such as Chondromimetic, which is used in treating underlying tissues and bone defects.-$5.0M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Goldman Sachs as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioGoldman Sachs' Fintech portfolio85 startups · $20BSector portfolioGoldman Sachs' AI portfolio45 startups · $85BSector portfolioGoldman Sachs' IT Services portfolio22 startups · $2.1BSector portfolioGoldman Sachs' Big Data & Analytics portfolio19 startups · $2.6BSector portfolioGoldman Sachs' Cybersecurity portfolio15 startups · $2.4BSector portfolioGoldman Sachs' Software portfolio14 startups · $1.5B
Raising from investors like Goldman Sachs?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.